Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Verdict comes after petitions filed by Rachana Gangu and others alleged that two women lost their lives in 2021 after taking the first dose of the Covishield vaccine ...

The founders of the biotech company that developed Comirnaty, the mRNA-based COVID-19 vaccine sold by BioNTech and Pfizer, will step down and form a new mRNA company.

A commission said the country is still grappling with the long-term consequences of both the pandemic and the policy response ...

The Dutch health council is recommending that the age for the annual coronavirus vaccine is raised from 60 to 70 and older from the coming autumn. The number of infections, hospital admissions and ...

Prasad's stint included several controversial vaccine decisions; the FDA is now searching for a new head for its vaccine division.

Moderna’s Omicron-adapted COVID-19 vaccines appear to reduce the risk of hospitalization and death in adults who are not pregnant or have a weakened immune system, according to a rapid review ...

That comes after the second phase of the Royal Commission of Inquiry released its findings on Tuesday.

BioNTech shares listed in New York fell about a fifth in pre-trading after the firm made the announcement and posted a loss of €1.1 billion ($2.1b) for 2025. Married couple Ugur ...

ACT has blasted the previous government for being power-hungry and NZ First maintained its reservations about the inquiry, but Labour defended the response as world-leading.

The 500-plus-page report looks at what it calls some of the "most difficult and divisive responses around vaccines and mandates".

The mechanism should not be viewed as an ‘admission of liability’ on part of the Union government, the bench said.